Patient Selection for Protected Percutaneous Coronary Intervention: Who Benefits the Most?

Seung-Hyun Kim1, Stefan Baumann1, Michael Behnes1

  • 1First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) Partner Site Heidelberg/Mannheim, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany.

Insights

Protected percutaneous coronary intervention (PCI) with mechanical support aids complex lesion revascularization in high-risk patients. This review guides patient selection for protected PCI to ensure safety and hemodynamic stability during procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Percutaneous coronary intervention (PCI) has advanced, enabling complete revascularization of complex coronary lesions.
  • Contemporary patients exhibit increased comorbidities, potentially reducing tolerance for complex PCI and increasing risks of hemodynamic instability.
  • Protected PCI utilizing mechanical circulatory support (MCS) has emerged as a strategy to mitigate these risks and achieve safe revascularization.

Purpose of the Study:

  • To provide practical approaches for patient selection in protected PCI.
  • To review current clinical data on the utility of protected PCI in high-risk patient populations.
  • To address the ongoing debate regarding optimal patient selection for protected PCI.

Main Methods:

  • Literature review of current clinical data.
  • Analysis of studies assessing the utility of protected PCI.
  • Evaluation of patient characteristics and outcomes in high-risk cohorts undergoing protected PCI.

Main Results:

  • Protected PCI is a viable strategy for complex coronary lesions in patients with high comorbidity burden.
  • Specific patient profiles and clinical indicators can help identify those most likely to benefit from protected PCI.
  • Evidence supports the use of protected PCI to maintain hemodynamic stability and achieve complete revascularization in select high-risk individuals.

Conclusions:

  • Protected PCI offers a valuable approach for managing complex coronary lesions in high-risk patients.
  • Careful patient selection is crucial for optimizing outcomes and safety in protected PCI procedures.
  • Further research may refine criteria for identifying patients who maximally benefit from protected PCI.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
130
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
21
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
57
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
187